Bottom line
Is YOVIX a good fund? The bottom line
YOVIX is the Institutional Class share class of Yorktown Small-cap Fund, a managed small-cap mutual fund from American Pension Investors.
It charges 1.35% — about $135 a year on every $10,000 invested, more expensive than 80% of small-cap funds we track.
It returned +9.6% over one year, +4.4% a year over five years (as of Dec 31, 2025, per its prospectus).
With $36.0 million in net assets and 93 holdings, its largest position is Guardant Health Inc (4.0%) and the top 10 make up 21.6% of the portfolio.
What stands out
- No front-end sales load
What to watch
- Expensive for its category (1.35%)
- 5-year return in the bottom quarter of its category
- Small fund ($36.0 million) — small funds are likelier to close
Updated Nov 19, 2026
What YOVIX invests in
Investment Objective The Fund seeks to achieve long term capital appreciation.
The Fund seeks to achieve its investment objective by investing in U.S. listed securities with market capitalization within the range of the targeted benchmark, the Russell 2000 Total Return Index. Under normal circumstances, the Fund invests at least 80% of its assets (plus the amount of any borrowings for investment purposes) in small cap companies. At any given time, the Fund may hold up to 15% of its assets in American Depositary Receipts. Typically, the Fund invests in approximately 50-200 stocks that pass the Advisers stringent quantitative and fundamental criteria. The Fund's investments in any one sector may exceed 25% of its net assets. As of February 28, 2026, over 25% of the Funds assets were invested in securities within the technology sector. The Adviser believes that the Fund is best able to achieve long-term capital appreciation through investments in securities of a…
From the fund's prospectus (filed May 27, 2026).
YOVIX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| YOVIX | +9.6% | +4.4% | — |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What YOVIX costs
On a $10,000 investment, YOVIX's 1.35% expense ratio costs about $135 a year. The prospectus estimates $2,039 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
YOVIX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Guardant Health Inc | 3.98% |
| 2 | Acm Research Inc | 2.90% |
| 3 | Chefs' Warehouse Inc (the) | 2.26% |
| 4 | Ies Holdings Inc | 1.94% |
| 5 | Palo Alto Networks Inc | 1.93% |
| 6 | Ionq Inc | 1.89% |
| 7 | Dave Inc | 1.81% |
| 8 | Axos Financial Inc | 1.69% |
| 9 | Mirum Pharmaceuticals Inc | 1.65% |
| 10 | Enova International Inc | 1.59% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 21.6% of the fund. See all top 25 holdings and asset mix →